semaglutide is not curbing my appetite Still Hungry on I'M NOT HUNGRY ANYMORE —

Why 3 months matters

A new study by EGDRCs Guillermo E Umpierrez found no difference in kidney outcomes among GLP-1 drugs dulaglutide, exenatide, liraglutide, but semaglutide showed lower risk of death and combined kidney/death outcomes in adults with type 2 diabetes.

Obesity is increasingly considered an independent risk factor for pancreatic cancer, with excess adiposity driving neoplastic transformation through chronic inflammation, insulin resistance, hyperinsulinemia, and activation of oncogenic pathways

You are not aloneabout 6 in 10 women in the U.S

Wondering how to safely stop GLP-1 meds like Ozempic or Wegovy